Plasmacytoid dendritic cells of the gut: Relevance to immunity and pathology

Clinical Immunology

Volumn 153, Issue 1, 2014, Pages 165-177

  Lombardi, Vincent C ^a   Khaiboullina, Svetlana F ^a,b  

^a UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

Autoimmunity; GALT; ; Gut; ; Interferon; ; PDC; ; Tolerance;

Indexed keywords

ANTIGEN; CYTOKINE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; CELL MATURATION; CELL POPULATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CROSS PRESENTATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; IMMUNOCOMPETENT CELL; INFLAMMATORY BOWEL DISEASE; INTESTINE; INTESTINE LYMPHATIC TISSUE; LYMPHOID TISSUE; PEYER PATCH; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNITY; GALT;; GUT;; INTERFERON;; PDC;; TOLERANCE;;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; AUTOIMMUNE DISEASES; CYTOKINES; DENDRITIC CELLS; GASTROINTESTINAL TRACT; HUMANS; PEYER'S PATCHES; TOLL-LIKE RECEPTORS;

EID: 84900019211     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2014.04.007     Document Type: Review

References (152)

1. Reizis B. Regulation of plasmacytoid dendritic cell development. Curr. Opin. Immunol. 2010, 22:206-211.
2. Fitzgerald-Bocarsly P., Dai J., Singh S. Plasmacytoid dendritic cells and type I IFN: 50years of convergent history. Cytokine Growth Factor Rev. 2008, 19:3-19.
3. Lande R., Gilliet M. Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann. N. Y. Acad. Sci. 2010, 1183:89-103.
4. Shortman K., Naik S.H. Steady-state and inflammatory dendritic-cell development. Nat. Rev. Immunol. 2007, 7:19-30.
5. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat. Rev. Immunol. 2007, 7:543-555.
6. Piccioli D., Tavarini S., Borgogni E., Steri V., Nuti S., Sammicheli C., Bardelli M., Montagna D., Locatelli F., Wack A. Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets. Blood 2007, 109:5371-5379.
7. Lindstedt M., Lundberg K., Borrebaeck C.A. Gene family clustering identifies functionally associated subsets of human in vivo blood and tonsillar dendritic cells. J. Immunol. 2005, 175:4839-4846.
8. Cella M., Jarrossay D., Facchetti F., Alebardi O., Nakajima H., Lanzavecchia A., Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 1999, 5:919-923.
9. Piqueras B., Connolly J., Freitas H., Palucka A.K., Banchereau J. Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 2006, 107:2613-2618.
10. Lennert K., Remmele W. Karyometric research on lymph node cells in man. I. Germinoblasts, lymphoblasts & lymphocytes. Acta Haematol. 1958, 19:99-113.
11. Muller-Hermelink H.K., Stein H., Steinmann G., Lennert K. Malignant lymphoma of plasmacytoid T-cells. Morphologic and immunologic studies characterizing a special type of T-cell. Am. J. Surg. Pathol. 1983, 7:849-862.
12. Facchetti F., de Wolf-Peeters C., Mason D.Y., Pulford K., van den Oord J.J., Desmet V.J. Immunohistochemical evidence for their monocyte/macrophage origin. Am. J. Pathol. 1988, 133:15-21.
13. Trinchieri G., Santoli D., Dee R.R., Knowles B.B. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation. J. Exp. Med. 1978, 147:1299-1313.
14. Siegal F.P., Kadowaki N., Shodell M., Fitzgerald-Bocarsly P.A., Shah K., Ho S., Antonenko S., Liu Y.J. The nature of the principal type 1 interferon-producing cells in human blood. Science 1999, 284:1835-1837.
15. Chen W., Antonenko S., Sederstrom J.M., Liang X., Chan A.S., Kanzler H., Blom B., Blazar B.R., Liu Y.J. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004, 103:2547-2553.
16. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 2011, 29:163-183.
17. Cisse B., Caton M.L., Lehner M., Maeda T., Scheu S., Locksley R., Holmberg D., Zweier C., den Hollander N.S., Kant S.G., Holter W., Rauch A., Zhuang Y., Reizis B. Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development. Cell 2008, 135:37-48.
18. Liu K., Nussenzweig M.C. Origin and development of dendritic cells. Immunol. Rev. 2010, 234:45-54.
19. Sawai C.M., Sisirak V., Ghosh H.S., Hou E.Z., Ceribelli M., Staudt L.M., Reizis B. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J. Exp. Med. 2013, 210(11):2151-2159.
20. Ghosh H.S., Cisse B., Bunin A., Lewis K.L., Reizis B. Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells. Immunity 2010, 33:905-916.
21. Wilson N.S., El-Sukkari D., Belz G.T., Smith C.M., Steptoe R.J., Heath W.R., Shortman K., Villadangos J.A. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 2003, 102:2187-2194.
22. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004, 5:987-995.
23. Reis E Sousa C. Dendritic cells in a mature age. Nat. Rev. Immunol. 2006, 6:476-483.
24. Gosling J., Dairaghi D.J., Wang Y., Hanley M., Talbot D., Miao Z., Schall T.J. Cutting edge: identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK. J. Immunol. 2000, 164:2851-2856.
25. Sousa C., Nunes C., Lucio M., Ferreira H., Lima J.L., Tavares J., Cordeiro-da-Silva A., Reis S. Effect of nonsteroidal anti-inflammatory drugs on the cellular membrane fluidity. J. Pharm. Sci. 2008, 97:3195-3206.
26. + dendritic cells for immune T cell areas. Cell 2010, 143:416-429.
27. Colonna M., Trinchieri G., Liu Y.J. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 2004, 5:1219-1226.
28. Soumelis V., Liu Y.J. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur. J. Immunol. 2006, 36:2286-2292.
29. Nagira M., Imai T., Hieshima K., Kusuda J., Ridanpaa M., Takagi S., Nishimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine secondary lymphoid-tissue chemokine that is a potent chemoattractant for lymphocytes and mapped to chromosome 9p13. J. Biol. Chem. 1997, 272:19518-19524.
30. Seth S., Oberdorfer L., Hyde R., Hoff K., Thies V., Worbs T., Schmitz S., Forster R. CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions. J. Immunol. 2011, 186:3364-3372.
31. Wendland M., Czeloth N., Mach N., Malissen B., Kremmer E., Pabst O., Forster R. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6347-6352.
32. Yoshida R., Imai T., Hieshima K., Kusuda J., Baba M., Kitaura M., Nishimura M., Kakizaki M., Nomiyama H., Yoshie O. Molecular cloning of a novel human CC chemokine EBI1-ligand chemokine that is a specific functional ligand for EBI1, CCR7. J. Biol. Chem. 1997, 272:13803-13809.
33. Steinman R.M., Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:351-358.
34. Hadeiba H., Sato T., Habtezion A., Oderup C., Pan J., Butcher E.C. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 2008, 9:1253-1260.
35. - but not plasmacytoid dendritic cells. J. Exp. Med. 2008, 205:1621-1634.
36. Dzionek A., Fuchs A., Schmidt P., Cremer S., Zysk M., Miltenyi S., Buck D.W., Schmitz J. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 2000, 165:6037-6046.
37. Rissoan M.C., Duhen T., Bridon J.M., Bendriss-Vermare N., Peronne C., de Saint Vis B., Briere F., Bates E.E. Subtractive hybridization reveals the expression of immunoglobulin-like transcript 7, Eph-B1, granzyme B, and 3 novel transcripts in human plasmacytoid dendritic cells. Blood 2002, 100:3295-3303.
38. Tel J., Smits E.L., Anguille S., Joshi R.N., Figdor C.G., de Vries I.J. Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities. Blood 2012, 120:3936-3944.
39. Coccia E.M., Severa M., Giacomini E., Monneron D., Remoli M.E., Julkunen I., Cella M., Lande R., Uze G. Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 2004, 34:796-805.
40. Hillyer P., Mane V.P., Schramm L.M., Puig M., Verthelyi D., Chen A., Zhao Z., Navarro M.B., Kirschman K.D., Bykadi S., Jubin R.G., Rabin R.L. Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol. Cell Biol. 2012, 90:774-783.
41. Szubin R., Chang W.L., Greasby T., Beckett L., Baumgarth N. Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. J. Interferon Cytokine Res. 2008, 28:749-763.
42. Noppert S.J., Fitzgerald K.A., Hertzog P.J. The role of type I interferons in TLR responses. Immunol. Cell Biol. 2007, 85:446-457.
43. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu. Rev. Immunol. 2005, 23:307-336.
44. Hochrein H., O'Keeffe M., Wagner H. Human and mouse plasmacytoid dendritic cells. Hum. Immunol. 2002, 63:1103-1110.
45. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A.M., Hartmann G. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 2001, 31:3026-3037.
46. Proietto A.I., O'Keeffe M., Gartlan K., Wright M.D., Shortman K., Wu L., Lahoud M.H. Differential production of inflammatory chemokines by murine dendritic cell subsets. Immunobiology 2004, 209:163-172.
47. Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis E Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303:1529-1531.
48. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., Bauer S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303:1526-1529.
49. + dendritic cells to produce type I IFN. J. Immunol. 2001, 166:2291-2295.
50. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., Hartmann G. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. J. Immunol. 2003, 170:4465-4474.
51. Bao M., Liu Y.J. Regulation of TLR7/9 signaling in plasmacytoid dendritic cells. Protein Cell 2013, 4:40-52.
52. Edwards A.D., Diebold S.S., Slack E.M., Tomizawa H., Hemmi H., Kaisho T., Akira S., Reis e Sousa C. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 2003, 33:827-833.
53. Mittag D., Proietto A.I., Loudovaris T., Mannering S.I., Vremec D., Shortman K., Wu L., Harrison L.C. Human dendritic cell subsets from spleen and blood are similar in phenotype and function but modified by donor health status. J. Immunol. 2011, 186:6207-6217.
54. Visintin A., Mazzoni A., Spitzer J.H., Wyllie D.H., Dower S.K., Segal D.M. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 2001, 166:249-255.
55. Kato H., Sato S., Yoneyama M., Yamamoto M., Uematsu S., Matsui K., Tsujimura T., Takeda K., Fujita T., Takeuchi O., Akira S. Cell type-specific involvement of RIG-I in antiviral response. Immunity 2005, 23:19-28.
56. Guiducci C., Ott G., Chan J.H., Damon E., Calacsan C., Matray T., Lee K.D., Coffman R.L., Barrat F.J. Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 2006, 203:1999-2008.
57. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434:1035-1040.
58. Honda K., Yanai H., Negishi H., Asagiri M., Sato M., Mizutani T., Shimada N., Ohba Y., Takaoka A., Yoshida N., Taniguchi T. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005, 434:772-777.
59. Taniguchi T., Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 2002, 14:111-116.
60. Dai J., Megjugorac N.J., Amrute S.B., Fitzgerald-Bocarsly P. Regulation of IFN regulatory factor-7 and IFN-alpha production by enveloped virus and lipopolysaccharide in human plasmacytoid dendritic cells. J. Immunol. 2004, 173:1535-1548.
61. Villadangos J.A., Young L. Antigen-presentation properties of plasmacytoid dendritic cells. Immunity 2008, 29:352-361.
62. Grouard G., Rissoan M.C., Filgueira L., Durand I., Banchereau J., Liu Y.J. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 1997, 185:1101-1111.
63. O'Doherty U., Peng M., Gezelter S., Swiggard W.J., Betjes M., Bhardwaj N., Steinman R.M. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994, 82:487-493.
64. Smit J.J., Rudd B.D., Lukacs N.W. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 2006, 203:1153-1159.
65. Liu Y.J. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 2005, 23:275-306.
66. Gilliet M., Liu Y.J. Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells. J. Exp. Med. 2002, 195:695-704.
67. Wakkach A., Fournier N., Brun V., Breittmayer J.P., Cottrez F., Groux H. Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 2003, 18:605-617.
68. + regulatory T cells. J. Immunol. 2004, 173:4433-4442.
69. Wilson N.S., Villadangos J.A. Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv. Immunol. 2005, 86:241-305.
70. Bastos-Amador P., Perez-Cabezas B., Izquierdo-Useros N., Puertas M.C., Martinez-Picado J., Pujol-Borrell R., Naranjo-Gomez M., Borras F.E. Capture of cell-derived microvesicles (exosomes and apoptotic bodies) by human plasmacytoid dendritic cells. J. Leukoc. Biol. 2012, 91:751-758.
71. Ochando J.C., Homma C., Yang Y., Hidalgo A., Garin A., Tacke F., Angeli V., Li Y., Boros P., Ding Y., Jessberger R., Trinchieri G., Lira S.A., Randolph G.J., Bromberg J.S. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 2006, 7:652-662.
72. Hoeffel G., Ripoche A.C., Matheoud D., Nascimbeni M., Escriou N., Lebon P., Heshmati F., Guillet J.G., Gannage M., Caillat-Zucman S., Casartelli N., Schwartz O., De la Salle H., Hanau D., Hosmalin A., Maranon C. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007, 27:481-492.
73. + T cells despite lower Ag uptake than myeloid dendritic cell subsets. Blood 2013, 121:459-467.
74. Dzionek A., Sohma Y., Nagafune J., Cella M., Colonna M., Facchetti F., Gunther G., Johnston I., Lanzavecchia A., Nagasaka T., Okada T., Vermi W., Winkels G., Yamamoto T., Zysk M., Yamaguchi Y., Schmitz J. BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 2001, 194:1823-1834.
75. Meyer-Wentrup F., Benitez-Ribas D., Tacken P.J., Punt C.J., Figdor C.G., de Vries I.J., Adema G.J. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 2008, 111:4245-4253.
76. Tel J., Sittig S.P., Blom R.A., Cruz L.J., Schreibelt G., Figdor C.G., de Vries I.J. Targeting uptake receptors on human plasmacytoid dendritic cells triggers antigen cross-presentation and robust type I IFN secretion. J. Immunol. 2013, 191(10):5005-5012.
77. Sandgren K.J., Smed-Sorensen A., Forsell M.N., Soldemo M., Adams W.C., Liang F., Perbeck L., Koup R.A., Wyatt R.T., Karlsson Hedestam G.B., Lore K. Human plasmacytoid dendritic cells efficiently capture HIV-1 envelope glycoproteins via CD4 for antigen presentation. J. Immunol. 2013, 191:60-69.
78. Guy-Grand D., Vassalli P. Gut intraepithelial T lymphocytes. Curr. Opin. Immunol. 1993, 5:247-252.
79. de Heer H.J., Hammad H., Soullie T., Hijdra D., Vos N., Willart M.A., Hoogsteden H.C., Lambrecht B.N. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J. Exp. Med. 2004, 200:89-98.
80. Wollenberg A., Wagner M., Gunther S., Towarowski A., Tuma E., Moderer M., Rothenfusser S., Wetzel S., Endres S., Hartmann G. Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases. J. Invest. Dermatol. 2002, 119:1096-1102.
81. Iliev I.D., Matteoli G., Rescigno M. The yin and yang of intestinal epithelial cells in controlling dendritic cell function. J. Exp. Med. 2007, 204:2253-2257.
82. Contractor N., Louten J., Kim L., Biron C.A., Kelsall B.L. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J. Immunol. 2007, 179:2690-2694.
83. Li H.S., Gelbard A., Martinez G.J., Esashi E., Zhang H., Nguyen-Jackson H., Liu Y.J., Overwijk W.W., Watowich S.S. Cell-intrinsic role for IFN-alpha-STAT1 signals in regulating murine Peyer patch plasmacytoid dendritic cells and conditioning an inflammatory response. Blood 2011, 118:3879-3889.
84. + regulatory T cells and prevent the induction of airway hyper-reactivity. Mucosal Immunol. 2012, 5:432-443.
85. + plasmacytoid dendritic cells in the small intestine suppress development of intestinal inflammation in mice. Immunol. Lett. 2012, 146:64-69.
86. Woof J.M., Mestecky J. Mucosal immunoglobulins. Immunol. Rev. 2005, 206:64-82.
87. Cerutti A. The regulation of IgA class switching. Nat. Rev. Immunol. 2008, 8:421-434.
88. Chaudhuri J., Alt F.W. Class-switch recombination: interplay of transcription, DNA deamination and DNA repair. Nat. Rev. Immunol. 2004, 4:541-552.
89. Stavnezer J. Antibody class switching. Adv. Immunol. 1996, 61:79-146.
90. Tezuka H., Abe Y., Iwata M., Takeuchi H., Ishikawa H., Matsushita M., Shiohara T., Akira S., Ohteki T. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature 2007, 448:929-933.
91. Tezuka H., Abe Y., Asano J., Sato T., Liu J., Iwata M., Ohteki T. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity 2011, 34:247-257.
92. Faria A.M., Weiner H.L. Oral tolerance. Immunol. Rev. 2005, 206:232-259.
93. Kelsall B.L., Leon F. Involvement of intestinal dendritic cells in oral tolerance, immunity to pathogens, and inflammatory bowel disease. Immunol. Rev. 2005, 206:132-148.
94. Kraus T.A., Toy L., Chan L., Childs J., Mayer L. Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease. Gastroenterology 2004, 126:1771-1778.
95. Qiao S.W., Sollid L.M., Blumberg R.S. Antigen presentation in celiac disease. Curr. Opin. Immunol. 2009, 21:111-117.
96. Black K.E., Murray J.A., David C.S. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J. Immunol. 2002, 169:5595-5600.
97. Pabst O., Bernhardt G. The puzzle of intestinal lamina propria dendritic cells and macrophages. Eur. J. Immunol. 2010, 40:2107-2111.
98. Rescigno M. Intestinal dendritic cells. Adv. Immunol. 2010, 107:109-138.
99. Rescigno M., Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J. Clin. Invest. 2009, 119:2441-2450.
100. Bamboat Z.M., Stableford J.A., Plitas G., Burt B.M., Nguyen H.M., Welles A.P., Gonen M., Young J.W., DeMatteo R.P. Human liver dendritic cells promote T cell hyporesponsiveness. J. Immunol. 2009, 182:1901-1911.
101. Worbs T., Bode U., Yan S., Hoffmann M.W., Hintzen G., Bernhardt G., Forster R., Pabst O. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J. Exp. Med. 2006, 203:519-527.
102. Rescigno M. Dendritic cells in oral tolerance in the gut. Cell. Microbiol. 2011, 13:1312-1318.
103. + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
104. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
105. Iliev I.D., Spadoni I., Mileti E., Matteoli G., Sonzogni A., Sampietro G.M., Foschi D., Caprioli F., Viale G., Rescigno M. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 2009, 58:1481-1489.
106. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 2001, 167:188-195.
107. + regulatory T cells by oral antigen administration. J. Immunol. 2001, 167:4245-4253.
108. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265:1237-1240.
109. + T cells mediating skin inflammation. Blood 2003, 102:3295-3301.
110. + cytotoxic T cells induce relapsing colitis in normal mice. Gastroenterology 2006, 131:485-496.
111. Hue S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., Verkarre V., Fodil N., Bahram S., Cerf-Bensussan N., Caillat-Zucman S. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 2004, 21:367-377.
112. Goubier A., Dubois B., Gheit H., Joubert G., Villard-Truc F., Asselin-Paturel C., Trinchieri G., Kaiserlian D. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008, 29:464-475.
113. Dubois B., Joubert G., Gomez de Aguero M., Gouanvic M., Goubier A., Kaiserlian D. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 2009, 137:1019-1028.
114. Baumgart D.C., Metzke D., Guckelberger O., Pascher A., Grotzinger C., Przesdzing I., Dorffel Y., Schmitz J., Thomas S. Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis. Clin. Exp. Immunol. 2011, 166:46-54.
115. Baumgart D.C., Metzke D., Schmitz J., Scheffold A., Sturm A., Wiedenmann B., Dignass A.U. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005, 54:228-236.
116. Middel P., Raddatz D., Gunawan B., Haller F., Radzun H.J. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 2006, 55:220-227.
117. Mannon P.J., Leon F., Fuss I.J., Walter B.A., Begnami M., Quezado M., Yang Z., Yi C., Groden C., Friend J., Hornung R.L., Brown M., Gurprasad S., Kelsall B., Strober W. Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells. Clin. Exp. Immunol. 2009, 155:447-456.
118. De Meirleir K., Khaiboullina S., Fremont M., Hulstaert J., Rizvanov A., Palotas A., Lombardi V. Plasmacytoid dendritic cells in the duodenum of individuals diagnosed with myalgic encephalomyelitis are uniquely immunoreactive to antibodies to human endogenous retroviral proteins. In Vivo 2013, 27.
119. Whitehead W.E., Palsson O., Jones K.R. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?. Gastroenterology 2002, 122:1140-1156.
120. Chen J., Tan Z., Liu H., Liu Z., Wu Y., Li J. Expression of plasmacytoid dendritic cells, IRF-7, IFN-alpha mRNA in the lesions of psoriasis vulgaris. J. Huazhong Univ. Sci. Technol. Med. Sci. 2006, 26:747-749.
121. Diana J., Simoni Y., Furio L., Beaudoin L., Agerberth B., Barrat F., Lehuen A. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat. Med. 2013, 19:65-73.
122. Gottenberg J.E., Cagnard N., Lucchesi C., Letourneur F., Mistou S., Lazure T., Jacques S., Ba N., Ittah M., Lepajolec C., Labetoulle M., Ardizzone M., Sibilia J., Fournier C., Chiocchia G., Mariette X. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:2770-2775.
123. Lande R., Giacomini E., Serafini B., Rosicarelli B., Sebastiani G.D., Minisola G., Tarantino U., Riccieri V., Valesini G., Coccia E.M. Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis. J. Immunol. 2004, 173:2815-2824.
124. Stasiolek M., Bayas A., Kruse N., Wieczarkowiecz A., Toyka K.V., Gold R., Selmaj K. Impaired maturation and altered regulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 2006, 129:1293-1305.
125. Lande R., Ganguly D., Facchinetti V., Frasca L., Conrad C., Gregorio J., Meller S., Chamilos G., Sebasigari R., Riccieri V., Bassett R., Amuro H., Fukuhara S., Ito T., Liu Y.J., Gilliet M. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 2011, 3:73ra19.
126. Bengtsson A.A., Sturfelt G., Truedsson L., Blomberg J., Alm G., Vallin H., Ronnblom L. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000, 9:664-671.
127. Barrat F.J., Meeker T., Chan J.H., Guiducci C., Coffman R.L. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur. J. Immunol. 2007, 37:3582-3586.
128. Liao C., Hsu J., Kim Y., Hu D.Q., Xu D., Zhang J., Pashine A., Menke J., Whittard T., Romero N., Truitt T., Slade M., Lukacs C., Hermann J., Zhou M., Lucas M., Narula S., DeMartino J., Tan S.L. Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy. Arthritis Res. Ther. 2013, 15:R146.
129. Neighbour P.A., Miller A.E., Bloom B.R. Interferon responses of leukocytes in multiple sclerosis. Neurology 1981, 31:561-566.
130. Jacobs L., O'Malley J., Freeman A., Ekes R. Intrathecal interferon reduces exacerbations of multiple sclerosis. Science 1981, 214:1026-1028.
131. Ganguly D., Haak S., Sisirak V., Reizis B. The role of dendritic cells in autoimmunity. Nat. Rev. Immunol. 2013, 13:566-577.
132. Brenchley J.M., Douek D.C. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008, 1:23-30.
133. Kotler D.P., Gaetz H.P., Lange M., Klein E.B., Holt P.R. Enteropathy associated with the acquired immunodeficiency syndrome. Ann. Intern. Med. 1984, 101:421-428.
134. Dandekar S. Pathogenesis of HIV in the gastrointestinal tract. Curr. HIV/AIDS Rep. 2007, 4:10-15.
135. Sankaran S., George M.D., Reay E., Guadalupe M., Flamm J., Prindiville T., Dandekar S. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 2008, 82:538-545.
136. Ullrich R., Zeitz M., Riecken E.O. Enteric immunologic abnormalities in human immunodeficiency virus infection. Semin. Liver Dis. 1992, 12:167-174.
137. + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004, 200:749-759.
138. Chun T.W., Nickle D.C., Justement J.S., Meyers J.H., Roby G., Hallahan C.W., Kottilil S., Moir S., Mican J.M., Mullins J.I., Ward D.J., Kovacs J.A., Mannon P.J., Fauci A.S. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J. Infect. Dis. 2008, 197:714-720.
139. Yukl S.A., Gianella S., Sinclair E., Epling L., Li Q., Duan L., Choi A.L., Girling V., Ho T., Li P., Fujimoto K., Lampiris H., Hare C.B., Pandori M., Haase A.T., Gunthard H.F., Fischer M., Shergill A.K., McQuaid K., Havlir D.V., Wong J.K. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J. Infect. Dis. 2010, 202:1553-1561.
140. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003, 77:11708-11717.
141. Kotler D.P., Shimada T., Snow G., Winson G., Chen W., Zhao M., Inada Y., Clayton F. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. Aids 1998, 12:597-604.
142. + T cell depletion and viral replication in SIV infection. Science 1998, 280:427-431.
143. Fong L., Mengozzi M., Abbey N.W., Herndier B.G., Engleman E.G. Productive infection of plasmacytoid dendritic cells with human immunodeficiency virus type 1 is triggered by CD40 ligation. J. Virol. 2002, 76:11033-11041.
144. Patterson S., Rae A., Hockey N., Gilmour J., Gotch F. Plasmacytoid dendritic cells are highly susceptible to human immunodeficiency virus type 1 infection and release infectious virus. J. Virol. 2001, 75:6710-6713.
145. Donaghy H., Gazzard B., Gotch F., Patterson S. Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. Blood 2003, 101:4505-4511.
146. - plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load. Blood 2001, 98:2574-2576.
147. Chehimi J., Campbell D.E., Azzoni L., Bacheller D., Papasavvas E., Jerandi G., Mounzer K., Kostman J., Trinchieri G., Montaner L.J. Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals. J. Immunol. 2002, 168:4796-4801.
148. Feldman S., Stein D., Amrute S., Denny T., Garcia Z., Kloser P., Sun Y., Megjugorac N., Fitzgerald-Bocarsly P. Decreased interferon-alpha production in HIV-infected patients correlates with numerical and functional deficiencies in circulating type 2 dendritic cell precursors. Clin. Immunol. 2001, 101:201-210.
149. Reeves R.K., Evans T.I., Gillis J., Wong F.E., Kang G., Li Q., Johnson R.P. SIV infection induces accumulation of plasmacytoid dendritic cells in the gut mucosa. J. Infect. Dis. 2012, 206:1462-1468.
150. Schmidt B., Scott I., Whitmore R.G., Foster H., Fujimura S., Schmitz J., Levy J.A. Low-level HIV infection of plasmacytoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Virology 2004, 329:280-288.
151. Li H., Gillis J., Johnson R.P., Reeves R.K. Multi-functional plasmacytoid dendritic cells redistribute to gut tissues during simian immunodeficiency virus infection. Immunology 2013, 140:244-249.
152. Lehmann C., Jung N., Forster K., Koch N., Leifeld L., Fischer J., Mauss S., Drebber U., Steffen H.M., Romerio F., Fatkenheuer G., Hartmann P. Longitudinal analysis of distribution and function of plasmacytoid dendritic cells in peripheral blood and gut mucosa of HIV infected patients. J. Infect. Dis. 2014, 209(6):940-949.